Холтеровское мониторирование, 2013. Российский кардиологический журнал
 Скачать 0.68 Mb.
|
|
№ 2 (106) | 2014 64 148. Nagashima H, Masushima M, Oqawa A, Ohsuga A, Kaneko T, Yazaki T, Okajiama M. Cardiac arrhythmias in healthy children revelated by 24-hour ambulatory ECG monitoring. Ped Cardiology 1987; 8:103–110. 149. Kugler J. Sinus о dysfunction In: Gilette P., Garsoan A. (eds).Pediatric Arrhythmia. Electrophysiology and pacing.Philadelphia: WB Saunders Co;1990;250–300. 150. Макаров Л. М, Белоконь НА, Белозеров Ю. М, Калачанова Е. П. Характеристика суточной ЭКГ и регуляции ритма сердца у подростков. Кардиология 1990; 2:37–42. 151. Макаров Л. М, Чупрова С. Н, Капущак О. В, Верченко Е. Г. Холтеровское мониторирование в диагностике парасистолии. Кардиология 1998; 9:65–66. 152. Lown B., Wolf M. Approaches to sudden death from coronary heart disease Circulation 1971; 44 (1):130–42. 153. Moss A., Stern S., (ed) Noninvasive Electrocardiology. Clinical aspects of Holter monitoring. Cambridge: Saunders Co, University Press; 1997. p. 529. 154. Pieper.SJ., Hammill.SC. Heart rate variability: technique and investigational applications in cardiovascular medicine. Mayo.Clin.Proc. 1995; 70 (10): 955–64. 155. Tanabe T. Holter and echocradiographic assessment in long-term management of atrial fibrillation. 12 th Congress of the International Society for Holter and Noninvsive Electrocradiology. Athens-Greece. 2007; 57–58. 156. Oral Y., Veerreddy S. Prevalence of asymptomatic recurrences of atrial fibrillation after sussessful radiofreguency catheter ablation. J Cardiovascular Electrophysiol, 2004;15:920–24. 157. Hindricks T., Piorkowski C. Perception of atrial fibrillation before and after radiofreguency catheter ablation. Circulation 2005;112:307–313. 158. Kottkamp H., Tanner H. Time course and guantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesion. JACCC 2004;44:869–77. 159. Pokushalov E, Romanov A, Corbucci G, et al. Does AF burden measured by continuous monitoring during blanking period predict the response to ablation at 12-month follow-up? Heart Rhythm. 2012 Mar 23. (в печати. DiMarco JP, Philbrick JT. Use of ambulatory electrocardiographic (Holter) monitoring. Ann Intern Med 1990;113:53–68. 161. .Anderson JL, Gilbert EM, Alpert BL, et al. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy: a multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring: Flecainide Supraventricular Tachycardia Study Group. Circulation 1989;80:1557–70. 162. Graboys TB, Lown B, Podrid PJ, DeSilva R. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am J Cardiol. 1982 Sep;50 (3):437–43. 163. Kennedy HL. Late proarrhythmia and understanding the time of occurrence of proarrhythmia. Am J Cardiol 1990;66:1139–43. 164. Morganroth J, Pratt CM. Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine). Am J Cardiol 1989;63: 172. 165. Velebit V, Podrid P, Lown B. Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 1982; 65:886–894. 166. Wyse DG, Morganroth J, Ledingham R, et al. New insights into the definition and meaning of proarrhythmia during initiation of antiarrhythmic drug therapy from the Cardiac Arrhythmia Suppression Trial and its pilot study: the CAST and CAPS nvestigators. J Am Coll Cardiol 1994;23:1130–40. 167. Шубик Ю. В. Оценка эффективности и безопастности лечения аритмий с помощью холтеровского мониториррования. Вестник аритмологии 2002; 26:43–48. 168. Mulrow JP, Healy MJ, McKenna WJ. Variability of ventricular arrhythmias in hypertrophic cardiomyopathy and implications for treatment. Am J Cardiol 1986;58:615–8. 169. Pratt CM, Delclos G, Wierman AM, et al. The changing baseline of complex ventricular arrhythmias: a new consideration in assessing long-term antiarrhythmic drug therapy. N Engl J Med 1985;313: 1444–9. 170. Morganroth J, Michelson EL, Horowitz LN, et al. Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency. Circulation 1978;58:408–14. 171. Winkle RA, Peters F, Hall R. Characterization of ventricular tachyarrhythmias on ambulatory ECG recordings in post-myocardial infarction patients: arrhythmia detection and duration of recording, relationship between arrhythmia frequency and complexity, and day-to-day reproducibility. Am Heart J 1981;102:162–9. 172. The Cardiac Arrhythmia Pilot Study (CAPS) Investigators. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS. Am J Cardiol 1988;61:501–9. 173. Reiter MJ, Karagounis LA, Mann DE, et al. Reproducibility of drug efficacy predictions by Holter monitoring in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial: ESVEM Investigators. Am J Cardiol 1997;79:315–22. 174. Raeder EA, Hohnloser SH, Graboys TB, et al. Spontaneous variability and circadian distribution of ectopic activity in patients with malignant ventricular arrhythmia. J Am Coll Cardiol 1988;12:656–61. 175. Pratt CM, Slymen DJ, Wierman AM, et al. Analysis of the spontaneous variability of ventricular arrhythmias: consecutive ambulatory electrocardiographic recordings of ventricular tachycardia. Am J Cardiol 1985;56:67–72. 118. М. Гомирато Сандруччи, Г. Боно. Электрокардиография детского возраста, М Медицина 1966. с. 367. 119. Макаров Л. М. Особенности вариабельности циркадного ритма сердца в условиях свободной активности. Физиология человека т. 24 N 2 1998 с. Макаров Л. М. Особенности использования анализа вариабельности ритма сердца у больных с болезнями сердца. Физиология человека т. 28 N 3 2002 с. Sim I, McDonald KM, Lavori PW, et al.Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death.Circulation 1997;96:2823–9. 122. Huang SK, Messer JV, Denes P. Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: observations in 35 patients. Am J Cardiol 1983;51:507–12. 123. Kron J, Hart M, Schual-Berke S, et al. Idiopathic dilated cardiomyopathy: role of programmed electrical stimulation and Holter monitoring in predicting those at risk of sudden death. Chest 1988;93: 85–90. 124. Holmes J, Kubo SH, Cody RJ, et al. Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography. Am J Cardiol 1985;55:146–51. 125. Unverferth DV, Magorien RD, Moeschberger ML, et al. Factorsinfluencing the 1-year mortality of dilated cardiomyopathy. Am J Cardiol 1984;54:147–52. 126. Pelliccia F, Gallo P, Cianfrocca C, et al. Relation of complex ventricular ас an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933–40. 128. Dittrich H, Gilpin E, Nicod P, et al. Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol 1988;62:1–7. 129. Massin M, von Bernuth G. Normal ranges of heart rate variability during infancy and childhood. Pediatr Card i o l 1997;18:297–302. 130. Moss AJ, Carleen E, the Multicenter Postinfarction Research Group. Gender differences in the mortality risk associated with ventricular arrhythmias after myocardial infarction. In: Eaker E, Packard B, Wenger NK, et al, editors. Coronary heart disease in women. New York: Haymarket Doyma, Inc,1986:204–7. 131. Hindricks T., Piorkowski C. Perception of atrial fibrillation before and after radiofreguency catheter ablation. Circulation 2005;112:307–313. 132. Рябыкина Г. В, Соболев А. В. Вариабельность ритма сердца. М Стар’К; 1998. с. Соболев А. В. Методы анализа вариабельности сердечного ритма на длительных промежутках времени. М Медпрактика; 2009. с. Schmidt G., Malik M., Barthel P., et al. Heart rate turbulence after ventricular premature beats as predictor of mortality after acute myocardial infarction. Lancet, 1999; 353: 130–196 135. Lindgren KS, Makikallio TH, Seppanen T, et al. Heart rate turbulence after ventricular and atrial premature beats in subjects without structural heart disease. J Cardiovasc Electrophysiol 2003;14:447–52. 136. Tuomainen P, Peuhkurinen K, Kettunen R, Rauramaa R. Regular physical exercise, heart rate variability and turbulence in a 6-year randomized controlled trial in middle-aged men: the DNASCO study. Life Sci 2005;77:2723–34. 137. Grimm W, Sharkova J, Christ M, et al. Heart rate turbulence following ventricular premature beats in healthy controls. Ann Noninvasive Electrocardiol 2003;8:127–31. 138. Diaz J, Castellanos A, Moleiro F, et al. Relation between sinus rates preceding and following ectopic beats occurring in isolation and as episodes of bigeminy in young healthy subjects. Am J Cardiol 2002;90:332–5. 139. Schwab JO, Eichner G, Shlevkov N, et al. Impact of age and basic heart rate on heart rate turbulence in healthy persons. Pacing Clin Electrophysiol 2005;28 Suppl 1: S198–201. 140. Kowalewski M, Alifier M, Bochen D, Urban M. Heart rate turbulence in children — age and heart rate relationships. Pediatr Res 2007;62:710–4. 141. Макаров Л. М, Комолятова В. Н, Горлицкая О. В, Казанцева МА. Турбулентность ритма сердца у больных с некоронарогенными желудочковыми тахиаритмиями. Кардиология 2005; 4: 21–26. 142. Macfarlane PW. Renaissance in electrocardiography. Lancet 1999; 353: 1377–1379. 143. Bauer A, Malik M, Schmidt G et al. Heart Rate Turbulence: Standards of Measurement, Physiological Interpretation, and Clinical Use International Society for Holter and Noninvasive Electrophysiology Consensus JACC 2008;52 (17). 144. Bauer A., Rantelhardt J., Schneider R. et al. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet 2006; 367; 1674–1681. 145. Komoliatova V, Makarov L, Schmidt G, A. Muller: “Symmetry of Deceleration /Acceleration capacity as method assessment of the patients with cardiovascular diseases”. Abstracts 14-th Congress of the International Society for Holter and Noninvasive Electrocardiology (ISHNE 2011), 12-th Congress of Russian Society for Holter Monitoring and Noninvasive Electrocardiology (ROHMINE),26–28 april 2011, Moscow, Russia, page 152. 146. Southall D., Johnston F., Shinebourne E., Johnston P. 24-hour electrocardiographic study of heart rate and rhythm patterns in population of healthy children. Brit Heart J. 1981; 45:281–291. 147. Dickinson P, Scott O. Ambulatory electrocardiographie monitoring in 100 healthy teenage boys. Br Heart J 1984;51:171–183. К 50-ЛЕТИЮ РОССИЙСКОГО КАРДИОЛОГИЧЕСКОГО ОБЩЕСТВА 65 КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ. Swerdlow CD, Peterson J. Prospective comparison of Holter monitoring and electrophysiologic study in patients with coronary artery disease and sustained ventricular tachyarrhythmias. Am J Cardiol 1985;56:577–80. 203. Pritchett EL, Lee KL. Designing clinical trials for paroxysmal atrial tachycardia and other paroxysmal arrhythmias. J Clin Epidemiol 1988;41:851–8. 204. Jung F, DiMarco JP. Antiarrhythmic drug therapy in the treatmen of atrial fibrillation. Cardiol Clin 1996;14:507–20. 205. Page RL, Wilkinson WE, Clair WK, et al. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994;89:224–7. 206. Ardura J., Silva J., Khatib A., P. Aragon. Electrocardiogramma continuo de Holter en ninos. An Esp Pediatr, 1983; 19: p.88–99. 207. Porter J, Gilette C, McNamara G. 24 hour ambulatory ECG in detection and management of cardiac dysrhythmias in infants and children. Ped Cardiol 1980 1 203–208. 208. Макаров Л. М, Белозеров Ю. М. Артефакты при проведении Холтеровского мониторирования ЭКГ. Кардиология 1989;7:100–102. 209. Adamec J, Adamec R. ECG Holter. 2008, Springer+Business Media, LLC, p. 89. 210. Diamond TH, Smith R, Myburgh DP. Holter monitoring: a necessity for the evaluation of palpitations. S Afr Med J 1983;63:5–7. 211. Kapoor WN, Cha R, Peterson JR, et al. Prolonged electrocardiographic monitoring in patients with syncope: importance of frequent or repetitive ventricular ectopy. Am J Med 1987;82:20–8. 212. Kennedy HL, Underhill SJ. Frequent or complex ventricular ectopyin apparently healthy subjects: a clinical study of 25 cases. Am J Cardiol 1976;38:141–8. 213. Raftery EB, Cashman PM. Long-term recording of the electrocardiogramin a normal population. Postgrad Med J 1976;52 Suppl7:32–8. 214. Glasser SP, Clark PI, Applebaum HJ. Occurrence of frequent complex arrhythmias detected by ambulatory monitoring: findings inan apparently healthy asymptomatic elderly population. Chest 1979; 75:565–8. 215. Kostis JB, McCrone K, Moreyra AE, et al. Premature ventricular complexes in the absence of identifiable heart disease. Circulation 1981;63:1351–6. 216. Sosnowski M., Czyz Z., Petelenz T., Tendera M. Circadian variability of ventricular late potential after myocardial infarction. In: Electrocardiology 96: From cell to the body surface. World Scientific Publ.Co. J. Liebman (ed). 1997 USA p.407–410. 217. Lombardi F, Calosso E, Mascioli G et al. Utility of implantable loop recorder (Reveal Plus) in the diagnosis of unexplained syncope Europace 2005;7:19–24. 218. Макаров Л. М, Кондрыкинский ЕЛ, Мягков И. Ф. Сердцебиение у детей клиническая характеристика, тактика обследования и лечения. Педиатрия 2005; 2: 4–8. 219. Zhao L., Ozawa O., Tanigawa N., et al. Signal average electrocardiography directly from Holter monitor tape in patients with ventricular arrhythmias. In: Electrocardiology 96: From cell to the body surface. World Scientific Publ.Co. J. Liebman (ed). 1997 USA p.431–434. 220. Bass EB, Curtiss EI, Arena VC, et al. The duration of Holter monitoring in patients with syncope: is 24 hr enough? Arch Intern Med 1990;150:1073–1078. 221. Kinlay S, Leitch JW, Neil A, et al. Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with р a controlled clinical trial. Ann Intern Med 1996;124:16–20. 222. Schmidt SB, Jain AC. Diagnostic utility of memory equipped transtelephonic monitors. Am J Med Sci 1988;296:299–302. 223. Linzer M, Pritchett EL, Pontinen M, et al. Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope.Am J Cardiol 1990;66:214–9. 224. Shimada M, Akaishi M, Asakura K, et al. Usefulness of the newly developed transtelephonic electrocardiogram and computersupported response system. J Cardiol 1996;27:211–7. 225. Zeldis S. M., Levine B. J., Michelson E. L., Morganroth J. Cardiovascular complaints: correlation with cardiac arrhythmias on 24–hour ECG monitoring. Chest. 1980;78:456– 462. 226. Kroenke K, Arrington ME, Mangelsdorff AD. The prevalence of symptoms in medical outpatients and the adequacy of therapy. Arch Intern Med. 1990;150:1685–1689 227. Либис Р. А, Прокофьев А. Б, Коц Я. И. Оценка качества жизни у больных с аритмия- ми. Кардиология 1998;38 (3):49–51. 228. Santangelo R, Santomau ro M, Occhetta E et al. Loop Recorder Versus Conventional Diagnostic Strategy Recurrent Unexplained Palpitations (RUP) Study: Comparison of Implantable/ J. Am. Coll. Cardiol. 2007;49:1951–1956. 229. Дощицин В. Л. Лечение аритмий сердца. — М Медицина 1993. с. Viollier EH, Lutold BE, Scherrer W, Viollier AF, Viollier M. [To what extent do indications for or questioning of the 24–hour ECG in ambulatory practice correlate with established ECG findings?] Schweiz Med Wochenschr 1985;115 (10):346–9. 231. Jonas S, Klein I, Dimant J. Importance of Holter monitoring in patients with periodic cerebral symptoms. Ann Neurol 1977;1:470–4. 232. Kessler DK, Kessler KM. Is ambulatory electrocardiography useful inthe evaluation of patients with recent stroke? Chest 1995;107:916–8. 233. Wieling W, Ganzeboom KS, Krediet CT, et al. Initial diagnostic strategy in the case of transient losses of consciousness: the importance of the medical history. Ned Tijdschr Geneeskd 2003;147:849–854. 176. Anastasiou-Nana MI, Gilbert EM, Miller RH, et al. Usefulness of d, l sotalol for suppression of chronic ventricular arrhythmias. Am J Cardiol 1991;67:511–6. 177. Kennedy HL. Noncardiac adverse events and organ toxicity of moricizine during short- and long-term studies. Am J Cardiol1990;65:47D–50D. 178. Schmidt G, Ulm K, Barthel P. Variability of ventricular premature contractions (letter). Circulation 1989;79:1149–51. 179. Anderson JL, Anastasiou-Nana MI, Menlove RL, et al. Spontaneous variability in ventricular ectopic activity during chronic antiarrhythmic therapy. Circulation 1990;82:830–40. 180. Anastasiou-Nana MI, Menlove RL, Nanas JN, et al. Changes in spontaneous variability of ventricular ectopic activity as a unction of time in patients with chronic arrhythmias. Circulation 1988;78:286–95. 181. Toivonen L. Spontaneous variability in the frequency of ventricular premature complexes over prolonged intervals and mplications for antiarrhythmic treatment. Am J Cardiol 1987;60:608–12. 182. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on ortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406–12. 183. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781–8. 184. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction: the Cardiac Arrhythmia Suppression Trial II Investigators. N Engl J Med 1992;327:227–33. 185. Epstein AE, Hallstrom AP, Rogers WJ, et al. Mortality following ventricular arrhythmia suppression by encainide, lecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST). JAMA 1993;270:2451–5. 186. Wyse DG, Hallstrom A, McBride R, et al. Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in patients surviving open label titration but not randomized to double- blind therapy. J Am Coll Cardiol 1991;18:20–8. 187. Hallstrom AP, Greene HL, Huther ML. The healthy responder phenomenon in non- randomized clinical trials. CAST nvestigators. Stat Med 1991;10:1621–31. 188. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA 1993;270:1589–95. 189. Waldo AL, Camm AJ, deRuyter H, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction: the SWORD Investigators: Survival With Oral d-Sotalol. Lancet 1996;348:7–12. 190. Ceremuzynski L, Kleczar E, Krzeminska-Pakula M, et al. Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. J Am Coll Cardiol 1992;20:1056–62. 191. Doval HC, Nul DR, Grancelli HO, et al. Randomised trial of low-dose amiodarone in severe congestive heart failure: Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994;344:493–8. 192. The CASCADE Investigators. Randomized drug therapy in survivors of cardiac arrest (the CASCADE Study). Am J Cardiol 1993;72:280–7. 193. Cairns JA, Connolly SJ, Roberts R, et al. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT, Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 1997;349:675–82. 194. Julian DG, Camm AJ, Frangin G, et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT, European Myocardial Infarct Amiodarone Trial Investigators. Lancet 1997;349:667– 74. 195. Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia: Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995;333:77–82. 196. Graboys TB, Lown B, Podrid PJ, et al. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am J Cardiol 1982;50:437–43. 197. Lampert S, Lown B, Graboys TB, et al. Determinants of survival in patients with malignant ventricular arrhythmia associated with coronary artery disease. Am J Cardiol 1988;61:791–7. 198. Mitchell LB, Duff HJ, Manyari DE, et al. A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia. N Engl J Med 1987;317:1681–7. 199. Mason JW. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias: Electrophysiologic Study Versus Electrocardiographic Monitoring Investigators. N Engl J Med 1993;329:445–51. 200. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576–83. 201. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933–40. |